More than 100 people have died from taking the blood thinner heparin, the Food and Drug Administration said Tuesday, after imports of the drug were halted due to contamination linked to production in China.
The 103 deaths reported to the FDA of patients who had been using heparin occurred between January 2007 and February 2008, the agency said on its website. Sixty-two of those deaths were reported to have involved allergic reactions.
The FDA on March 5 said it had detected an unidentified contaminant in heparin injections sold by Baxter International pharmaceuticals.
It was determined that most of the active ingredients in the drug came from a plant in Changzou, China working with Wisconsin-based Scientific Protein Laboratories, which supplies Baxter.
Imports of heparin were halted last month to test for contaminants possibly linked to several deaths and severe allergic reactions.